-
Study aim
-
Efficacy of Pentoxifylline in pain assessment after Laminectomy surgery
-
Design
-
The clinical trial with the control group, with parallel, double-blind, randomized, phase-referred groups, on 72 patients.www.randomization.com site is used for randomization.
-
Settings and conduct
-
In 1401, 72 patients will be included in the study in Shah Vali hospita haspital, the study will be double-blind, and the Pain Assessor and patient will be unaware of the grouping of patients. To blind the patients, placebo and for blinding the evaluator, the group encoding will be used in the form of a and b. One hour before surgery, one hour and 24 hours after surgery, pain levels will be evaluated in both groups using VAS. The reported pain is compared between the two groups and then compared.
-
Participants/Inclusion and exclusion criteria
-
Entry requirements: Patients who are candidates for Laminectomy surgery and are over 15 years old
Non-entry requirements: Patients with alcohol or substance abuse, patients who smoked,
pregnant mothers, those with liver disease, diabetes, immunodeficiency (the use of immunosuppressive drugs or chemotherapy), AIDS, acute bowel disease, cancer,
Children under the age of 15 and people older than 75 who are getting information from them are difficult.
-
Intervention groups
-
Intervention group ": In this group, one capsule of pentoxylline supplied by Farabi Pharmaceutical Company is given to the patient one hour before laminectomy.
"Control Group": In this group, one hour before laminectomy, a 400 mg capsule of pentoxylline whose contents are emptied and filled with starch is given to the patient.
-
Main outcome variables
-
The rate of pain based on the VAS